Literature DB >> 27520894

Neurological soft signs and cognitive functions: Amongst euthymic bipolar I disorder cases, non-affected first degree relatives and healthy controls.

Srikant Sharma1, Triptish Bhatia2, Sati Mazumdar3, Smita N Deshpande4.   

Abstract

Both neurological soft signs (NSS) and cognitive deficits are present among euthymic bipolar patients. NSS could be related to neurocognitive performance, but this is not explored thoroughly. Healthy relatives of patients may also suffer from similar deficits. This study compared NSS and cognitive functions in euthymic Bipolar I Disorder (BPI) cases to their non-affected first degree relatives and healthy controls. We also investigated the association between NSS and cognitive functions in these three groups. NSS were assessed in three groups using Neurological Evaluation Scale-revised (NES-r). Eight cognitive domains were assessed in 31 euthymic BPI cases, their 30 non-affected first degree relatives and 30 healthy controls using Computerized Neurocognitive Battery (CNB). Euthymic BPI patients had significantly more NSS than non-affected first degree relatives on 5/7 tests (p-value ranges from 0.042 to p=0.0001) and healthy controls on all tests (p-value from 0.042 to <0.0001). Non-affected first degree relatives and controls did not have any significant difference. BPI participants performed worse than their non-affected first degree relatives on one neurocognitive domain of CNB (spatial memory accuracy, p=0.03) and healthy controls on four domains (spatial memory accuracy (p=0.04), abstraction and mental flexibility efficiency (p=0.04), spatial memory efficiency (p=0.04), and emotion efficiency (p=0.04). Non-affected relatives and healthy controls were similar on neurocognitive domains. Accuracy and efficiency indices of some specific cognitive domains were negatively associated with AV rating and tap copying NSS ratings.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Cognition; Euthymic; Neurological soft signs

Mesh:

Year:  2016        PMID: 27520894      PMCID: PMC5061649          DOI: 10.1016/j.ajp.2016.04.002

Source DB:  PubMed          Journal:  Asian J Psychiatr        ISSN: 1876-2018


  49 in total

1.  Assessing cognitive function in bipolar disorder: challenges and recommendations for clinical trial design.

Authors:  Katherine E Burdick; Terence A Ketter; Joseph F Goldberg; Joseph R Calabrese
Journal:  J Clin Psychiatry       Date:  2015-03       Impact factor: 4.384

2.  Inter-rater reliability of the neurological examination in schizophrenia.

Authors:  R D Sanders; S D Forman; J N Pierri; R W Baker; M E Kelley; D P Van Kammen; M S Keshavan
Journal:  Schizophr Res       Date:  1998-02-09       Impact factor: 4.939

3.  The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia.

Authors:  R W Buchanan; D W Heinrichs
Journal:  Psychiatry Res       Date:  1989-03       Impact factor: 3.222

4.  Prodromal interventions for schizophrenia vulnerability: the risks of being "at risk".

Authors:  Cheryl Corcoran; Dolores Malaspina; Laura Hercher
Journal:  Schizophr Res       Date:  2005-03-01       Impact factor: 4.939

5.  Persistence of cognitive impairment and its negative impact on psychosocial functioning in lithium-treated, euthymic bipolar patients: a 6-year follow-up study.

Authors:  E Mora; M J Portella; I Forcada; E Vieta; M Mur
Journal:  Psychol Med       Date:  2012-08-31       Impact factor: 7.723

6.  A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder.

Authors:  Lucy J Robinson; Jill M Thompson; Peter Gallagher; Utpal Goswami; Allan H Young; I Nicol Ferrier; P Brian Moore
Journal:  J Affect Disord       Date:  2006-03-06       Impact factor: 4.839

Review 7.  The continuity of psychotic experiences in the general population.

Authors:  L C Johns; J van Os
Journal:  Clin Psychol Rev       Date:  2001-11

Review 8.  The feasibility of neuropsychological endophenotypes in the search for genes associated with bipolar affective disorder.

Authors:  David C Glahn; Carrie E Bearden; Tara A Niendam; Michael A Escamilla
Journal:  Bipolar Disord       Date:  2004-06       Impact factor: 6.744

9.  Neurologic features and psychopathology in schizophrenic disorders.

Authors:  T C Manschreck; D Ames
Journal:  Biol Psychiatry       Date:  1984-05       Impact factor: 13.382

10.  Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives.

Authors:  Emre Bora; Murat Yucel; Christos Pantelis
Journal:  J Affect Disord       Date:  2008-08-05       Impact factor: 4.839

View more
  2 in total

1.  Neurocognitive performance as an endophenotype for mood disorder subgroups.

Authors:  Alison K Merikangas; Lihong Cui; Monica E Calkins; Tyler M Moore; Ruben C Gur; Raquel E Gur; Kathleen R Merikangas
Journal:  J Affect Disord       Date:  2017-03-10       Impact factor: 4.839

2.  Clinical, Cognitive, and Neuroimaging Evidence of a Neurodevelopmental Continuum in Offspring of Probands With Schizophrenia and Bipolar Disorder.

Authors:  Gisela Sugranyes; Elena de la Serna; Roger Borras; Vanessa Sanchez-Gistau; Jose C Pariente; Soledad Romero; Inmaculada Baeza; Covadonga M Díaz-Caneja; Elisa Rodriguez-Toscano; Carmen Moreno; Miguel Bernardo; Dolores Moreno; Eduard Vieta; Josefina Castro-Fornieles
Journal:  Schizophr Bull       Date:  2017-10-21       Impact factor: 9.306

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.